Combining GLP‐1 receptor agonists with insulin: therapeutic rationales and clinical findings
T Vilsbøll - Diabetes, Obesity and Metabolism, 2013 - Wiley Online Library
Due to the increasing prevalence of type 2 diabetes mellitus (T2DM), the emergent trend
towards diagnosis in younger patients and the progressive nature of this disease, many …
towards diagnosis in younger patients and the progressive nature of this disease, many …
Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings
JJ Holst, T Vilsbøll - Diabetes, Obesity and Metabolism Online, 2013 - research.regionh.dk
Due to the increasing prevalence of type 2 diabetes mellitus (T2DM), the emergent trend
towards diagnosis in younger patients and the progressive nature of this disease, many …
towards diagnosis in younger patients and the progressive nature of this disease, many …
Combining GLP‐1 receptor agonists with insulin: therapeutic rationales and clinical findings
JJ Holst, T Vilsbøll - Diabetes, Obesity and Metabolism, 2012 - infona.pl
Due to the increasing prevalence of type 2 diabetes mellitus (T2DM), the emergent trend
towards diagnosis in younger patients and the progressive nature of this disease, many …
towards diagnosis in younger patients and the progressive nature of this disease, many …
Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings.
JJ Holst, T Vilsbøll - Diabetes, Obesity & Metabolism, 2013 - search.ebscohost.com
Due to the increasing prevalence of type 2 diabetes mellitus (T2DM), the emergent trend
towards diagnosis in younger patients and the progressive nature of this disease, many …
towards diagnosis in younger patients and the progressive nature of this disease, many …
Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings
JJ Holst, T Vilsbøll - Diabetes, obesity & metabolism, 2013 - pubmed.ncbi.nlm.nih.gov
Due to the increasing prevalence of type 2 diabetes mellitus (T2DM), the emergent trend
towards diagnosis in younger patients and the progressive nature of this disease, many …
towards diagnosis in younger patients and the progressive nature of this disease, many …
Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings.
JJ Holst, T Vilsbøll - Diabetes, Obesity & Metabolism, 2012 - europepmc.org
Due to the increasing prevalence of type 2 diabetes mellitus (T2DM), the emergent trend
towards diagnosis in younger patients and the progressive nature of this disease, many …
towards diagnosis in younger patients and the progressive nature of this disease, many …